UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Vir Biotechnology Inc (VIR)

Vir Biotechnology Inc (VIR)
5.00 x 7 7.20 x 1
Pre-market by (Cboe BZX)
5.61 +0.11 (+2.00%) 04/21/25 [NASDAQ]
5.00 x 7 7.20 x 1
Pre-market 5.61 unch (unch) 16:00 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
5.38
Day High
5.86
Open 5.43
Previous Close 5.50 5.50
Volume 1,097,900 1,097,900
Avg Vol 1,286,985 1,286,985
Stochastic %K 34.51% 34.51%
Weighted Alpha -61.26 -61.26
5-Day Change +0.08 (+1.45%) +0.08 (+1.45%)
52-Week Range 4.95 - 14.45 4.95 - 14.45
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 754,287
  • Shares Outstanding, K 137,143
  • Annual Sales, $ 74,210 K
  • Annual Income, $ -521,960 K
  • EBIT $ -587 M
  • EBITDA $ -567 M
  • 60-Month Beta 1.14
  • Price/Sales 10.04
  • Price/Cash Flow N/A
  • Price/Book 0.65

Options Overview Details

View History
  • Implied Volatility 169.52% ( +44.15%)
  • Historical Volatility 65.58%
  • IV Percentile 99%
  • IV Rank 97.99%
  • IV High 172.54% on 04/08/25
  • IV Low 22.09% on 08/13/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 45
  • Volume Avg (30-Day) 134
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 5,105
  • Open Int (30-Day) 7,438

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.83
  • Number of Estimates 5
  • High Estimate -0.67
  • Low Estimate -1.03
  • Prior Year -0.48
  • Growth Rate Est. (year over year) -72.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.95 +13.33%
on 04/09/25
Period Open: 6.93
7.22 -22.30%
on 03/25/25
-1.32 (-19.05%)
since 03/21/25
3-Month
4.95 +13.33%
on 04/09/25
Period Open: 10.42
11.39 -50.75%
on 01/23/25
-4.81 (-46.16%)
since 01/21/25
52-Week
4.95 +13.33%
on 04/09/25
Period Open: 7.95
14.45 -61.18%
on 01/08/25
-2.34 (-29.43%)
since 04/19/24

Most Recent Stories

More News
VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates

Vir Biotechnology, Inc. VIR announced encouraging initial data from a phase I study that evaluated its investigational pipeline candidates, VIR-5818 and VIR-5500, for the treatment of various solid tumors.While...

CTMX : 0.7499 (+14.31%)
PBYI : 2.86 (unch)
CSTL : 21.14 (-1.72%)
VIR : 5.61 (+2.00%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

SBFM : 1.2900 (+3.20%)
INO : 1.7800 (+2.30%)
MRNA : 25.13 (+1.68%)
PFE : 22.04 (-0.45%)
VIR : 5.61 (+2.00%)
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031

SBFM : 1.2900 (+3.20%)
INO : 1.7800 (+2.30%)
MRNA : 25.13 (+1.68%)
PFE : 22.04 (-0.45%)
VIR : 5.61 (+2.00%)
From laggards to leaders: Small caps on the rise

Despite large-cap dominance, signs suggest a shift to small-cap leadership. Valuations, positive Q3 results, and historical patterns point to potential gains.

NVDA : 96.91 (-4.51%)
META : 484.66 (-3.35%)
MDY : 490.29 (-2.29%)
RCUS : 7.71 (-2.16%)
XLC : 88.18 (-2.25%)
SPSM : 36.81 (-2.00%)
TSLA : 227.50 (-5.75%)
PHM : 93.11 (-1.94%)
XLK : 187.88 (-2.58%)
RCL : 189.51 (-1.65%)
CDMO : 12.49 (+0.08%)
SPY : 513.88 (-2.38%)
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 3.23 (-9.52%)
INSM : 69.51 (-4.32%)
VIR : 5.61 (+2.00%)
CODX : 0.3552 (+2.25%)
ANTX : 1.2500 (-0.79%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

ALBT : 3.23 (-9.52%)
INSM : 69.51 (-4.32%)
VIR : 5.61 (+2.00%)
CODX : 0.3552 (+2.25%)
ANTX : 1.2500 (-0.79%)
Is Vir Biotechnology Stock a Buy?

The biotech is out to prove that it isn't just a "pandemic stock."

VIR : 5.61 (+2.00%)
Why Shares of Vir Biotechnology Are Plunging Thursday

The company had disappointing trial news for one of its lead therapies.

GILD : 104.33 (-0.20%)
GSK : 36.45 (+1.45%)
VIR : 5.61 (+2.00%)
Brii Biosciences Provides Latest Clinical Development and Corporate Updates

Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets New data from...

VBIV : 0.0653 (-50.87%)
VIR : 5.61 (+2.00%)
ANTX : 1.2500 (-0.79%)
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASLâ„¢ Congress 2023

/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio", "we", or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve...

VBIV : 0.0653 (-50.87%)
VIR : 5.61 (+2.00%)

Business Summary

Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The company's development pipeline consists of product candidates targeting the hepatitis B virus, influenza A, human immunodeficiency virus...

See More

Key Turning Points

3rd Resistance Point 6.33
2nd Resistance Point 6.10
1st Resistance Point 5.85
Last Price 5.61
1st Support Level 5.37
2nd Support Level 5.14
3rd Support Level 4.89

See More

52-Week High 14.45
Fibonacci 61.8% 10.82
Fibonacci 50% 9.70
Fibonacci 38.2% 8.58
Last Price 5.61
52-Week Low 4.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro